Form 8-K - Current report:
SEC Accession No. 0000950170-24-114481
Filing Date
2024-10-15
Accepted
2024-10-15 09:15:07
Documents
12
Period of Report
2024-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glto-20241015.htm   iXBRL 8-K 60088
2 EX-99.1 glto-ex99_1.htm EX-99.1 12181
  Complete submission text file 0000950170-24-114481.txt   195577

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT glto-20241015.xsd EX-101.SCH 26988
14 EXTRACTED XBRL INSTANCE DOCUMENT glto-20241015_htm.xml XML 4875
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39655 | Film No.: 241369634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)